Finance

Lists
603566:SHA
Pulike Biological Engineering Inc
CN¥10.12
+0.70%
(+0.070) 1D
Oct 16, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603566...
Open
CN¥10.08
High
CN¥10.43
Low
CN¥10.04
Mkt. cap
3.55B
Avg. vol.
2.59M
Volume
4.69M
Dividend
5.93%
Quarterly dividend
CN¥0.15
Ex-dividend date
Jun 16, 2026
P/E ratio
23.50
52-wk high
CN¥14.58
52-wk low
CN¥9.56
EPS
CN¥0.43
Shares outstanding
323.74M
No. of employees
2K
Open
CN¥10.08
High
CN¥10.43
Low
CN¥10.04
Mkt. cap
3.55B
Avg. vol.
2.59M
Volume
4.69M
Dividend
5.93%
Quarterly dividend
CN¥0.15
Ex-dividend date
Jun 16, 2026
P/E ratio
23.50
52-wk high
CN¥14.58
52-wk low
CN¥9.56
EPS
CN¥0.43
Shares outstanding
323.74M
No. of employees
2K
News stories
From web sources and news partners
About Pulike Biological Engineering Inc
CEO-
Employees1.52K
Founded1995
Headquarters-
SectorPharmaceutical industry
Websitepulike.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
263.58M
266.87M
249.24M
242.03M
Cost of goods sold
100.95M
111.89M
112.42M
105.17M
Cost of revenue
100.95M
111.89M
112.42M
105.17M
Research and development expenses
23.68M
32.28M
20.02M
31.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
95.68M
103.92M
71.24M
76.01M
Operating expense
124.41M
142.59M
97.95M
117.02M
Total operating expenses
225.35M
254.48M
210.37M
222.20M
Operating income
38.23M
12.39M
38.87M
19.83M
Other non operating income
688.80K
-993.07K
-144.35K
-284.28K
EBT including unusual items
45.54M
30.98M
45.02M
28.40M
EBT excluding unusual items
38.42M
15.98M
40.06M
23.95M
Income tax expense
4.58M
3.13M
9.36M
185.73K
Effective tax rate
10.06%
10.09%
20.80%
0.65%
Other operating expenses
4.26M
3.33M
4.62M
3.65M
Net income
40.95M
27.86M
40.73M
36.59M
Net profit margin
15.54%
10.44%
16.34%
15.12%
Earnings per share
-
-
-
-
Interest and investment income
-
4.96M
1.54M
5.30M
Interest expense
-666.87K
-59.75K
-201.53K
-105.64K
Net interest expenses
-666.87K
4.90M
1.34M
5.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
68.04M
42.42M
68.89M
58.02M
Gain or loss from assets sale
-599.30K
630.42K
-
-33.88K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps